AIDS
AIDS
•By the end of 1985, there were more than 20,000 reported
cases of AIDS, with at least one case in every region of the
world.
NEWLY DIAGNOSED
CASES
In February 2022, there were 1,054 confirmed HIV-positive individuals
reported to the HIV/AIDS & ART Registry of the Philippines (HARP) and
were accounted to the total (96,266)b reported cases since January
1984.
Ninety-five percent (1,006) of the reported cases were male while 5% (48)
were females. Of the total reported cases this period, 60% (630) were
cisgendere , 3% (35) were transgender women, 25% (260) identified their
gender neither as man or woman. While 12%(129) do not have data on
gender identity.
Further,
50% (528) of the cases were 25-34 years
old at the time of diagnosis,
30% (311) were 15-24 years old,
18% (188) were 35-49 years old,
2% (26) were 50 years and older,
and <1%(1) was less than 15 years old.
The median age was 28 years old (age
range: 2-70 years old).
February 2022, there were 861 people with HIV who were initiated on
ART. All were on first line regimen. The median CD4 of these patients
upon enrollment was at 231 cells/mm3. A total of 57,401 people living
with HIV (PLHIV) reported were presently on ART as of February 2022.
Ninety-six percent (55,233) were males. The age of reported cases
ranged from 1 to 80 years (median: 32 years old). Ninety-six percent
were on the first line regimen, 4% were on the second line, and <1%
were on the other line of regimen.
Anti-Retroviral Therapy
(ART)
AZT is Developed
In 1987, the first antiretroviral
medication for HIV, azidothymidine
(AZT), became available.
Numerous other medications for HIV
are now available, and are typically
used together in what’s known as
antiretroviral therapy (ART) or highly
active antiretroviral treatment
(HAART).
Anti-Retroviral Therapy
(ART)
First-line ART regimens consisted of two nucleoside/nucleotide
reverse transcriptase inhibitors (NRTIs; zidovudine or
stavudine and lamivudine) and one non-nucleoside reverse
transcriptase inhibitor (NNRTI; nevirapine or efavirenz), while
second-line consisted of ritonavir-boosted lopinavir with 2
NRTIs.
√ By remaining faithful
√ Using condoms
√ Not sharing needles, razors or brushes
√ Examining blood before transferring it to a patient
√ Sterilizing dental & surgical instruments
√ Taking medical treatment while delivering and
breastfeeding a child
Group 5
Abegail Meguiso
Shane Lagudas
Jonnah Mae Babao
Aida Kamin